These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 32205037)

  • 1. Improved Prognostication for the Updated AJCC Breast Cancer Pathological Prognostic Staging Varied in Higher-Stage Groups.
    Hu J; Fung MW; Tsang JY; Poon IK; Chan SK; Cheung SY; Hu H; Zhou D; Tse GM
    Clin Breast Cancer; 2020 Jun; 20(3):253-261.e7. PubMed ID: 32205037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
    Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
    BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
    Lundgren C; Bendahl PO; Ekholm M; Fernö M; Forsare C; Krüger U; Nordenskjöld B; Stål O; Rydén L
    Breast Cancer Res; 2020 Dec; 22(1):140. PubMed ID: 33357231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Pathological Prognostic Stage and Anatomic Stage Groups According to the Updated Version of the American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8th Edition.
    Ibis K; Ozkurt S; Kucucuk S; Yavuz E; Saip P
    Med Sci Monit; 2018 May; 24():3637-3643. PubMed ID: 29849016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01).
    Krecko LK; Neuman HB; Greenberg CC; Wilke LG; Hanlon BM; Edge SB; Ruddy KJ; Partridge AH; Le-Rademacher J; Yang DY; Havlena J; R Schumacher J
    Ann Surg Oncol; 2024 Sep; 31(9):5880-5887. PubMed ID: 38825628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer.
    Xu L; Li JH; Ye JM; Duan XN; Cheng YJ; Xin L; Liu Q; Zhou B; Liu YH
    Chin Med J (Engl); 2017 Aug; 130(16):1945-1952. PubMed ID: 28776547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.
    Tang L; Ishikawa Y; Matsushita H; Jingu K
    Int J Clin Oncol; 2020 Aug; 25(8):1499-1505. PubMed ID: 32356049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study in China.
    Liu X; Zheng D; Wu Y; Luo C; Fan Y; Zhong X; Zheng H
    BMC Cancer; 2021 Mar; 21(1):226. PubMed ID: 33673816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher ER load is not associated with better outcome in stage 1-3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer.
    Noordhoek I; de Groot AF; Cohen D; Liefers GJ; Portielje JEA; Kroep JR
    Breast Cancer Res Treat; 2019 Jul; 176(1):27-36. PubMed ID: 30997625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and prognostic characteristic features of triple negative and nontriple negative breast cancer at a tertiary care hospital.
    Mohapatra M
    J Cancer Res Ther; 2023; 19(5):1186-1193. PubMed ID: 37787282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.
    Chavez-MacGregor M; Mittendorf EA; Clarke CA; Lichtensztajn DY; Hunt KK; Giordano SH
    Oncologist; 2017 Nov; 22(11):1292-1300. PubMed ID: 28592619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.
    Bakre MM; Ramkumar C; Attuluri AK; Basavaraj C; Prakash C; Buturovic L; Madhav L; Naidu N; R P; Somashekhar SP; Gupta S; Doval DC; Pegram MD
    Cancer Med; 2019 Apr; 8(4):1755-1764. PubMed ID: 30848103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers.
    Tsang JY; Ho CS; Ni YB; Shao Y; Poon IK; Chan SK; Cheung SY; Shea KH; Marabi M; Tse GM
    Cancer Immunol Immunother; 2020 May; 69(5):799-811. PubMed ID: 32055918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.
    Zhang M; Zhang S; Wen Y; Wang Y; Wei Y; Liu H; Zhang D; Su J; Wang F; Zhang Y
    PLoS One; 2015; 10(11):e0142279. PubMed ID: 26550991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic validation and therapeutic decision-making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy.
    Wu SG; Wang J; Lei J; Lian CL; Hua L; Zhou J; He ZY
    Clin Transl Med; 2020 Jan; 10(1):125-136. PubMed ID: 32508053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overall survival of breast cancer patients without adjuvant therapy.
    Onishi S; Sawaki M; Ishiguro J; Kataoka A; Iwase M; Sugino K; Adachi Y; Gondo N; Kotani H; Yoshimura A; Hattori M; Matsuo K; Yatabe Y; Iwata H
    Surg Today; 2019 Jul; 49(7):610-620. PubMed ID: 30730005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.
    Mittendorf EA; Chavez-MacGregor M; Vila J; Yi M; Lichtensztajn DY; Clarke CA; Giordano SH; Hunt KK
    Ann Surg Oncol; 2017 Nov; 24(12):3502-3509. PubMed ID: 28726077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of young age (below 40 years) on oncologic outcomes in Lebanese patients with breast cancer: a matched cohort study.
    Sbaity E; Tamim H; El-Hajj Fuleihan G; Abbas J; Zahwe M; El Sayed R; Shamseddine A
    BMC Cancer; 2024 May; 24(1):560. PubMed ID: 38704543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of immunohistochemical markers in women with breast cancer.
    Caparlar MA; Dokcu S; Erogu A
    Niger J Clin Pract; 2023 Mar; 26(3):314-318. PubMed ID: 37056105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors.
    Yang PJ; Tsai EM; Hou MF; Lee YJ; Wang TN
    Breast Cancer; 2024 Jul; 31(4):659-670. PubMed ID: 38652345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.